Imaging  ||| S:0 E:8 ||| JJ
characteristics  ||| S:8 E:24 ||| NNS
of  ||| S:24 E:27 ||| IN
basilar  ||| S:27 E:35 ||| JJ
artery  ||| S:35 E:42 ||| NN
hypoplasia  ||| S:42 E:53 ||| NN
To  ||| S:53 E:56 ||| TO
determine  ||| S:56 E:66 ||| VB
the  ||| S:66 E:70 ||| DT
imaging  ||| S:70 E:78 ||| JJ
characteristics  ||| S:78 E:94 ||| NNS
of  ||| S:94 E:97 ||| IN
basilar  ||| S:97 E:105 ||| JJ
artery  ||| S:105 E:112 ||| NN
hypoplasia  ||| S:112 E:123 ||| NNS
( ||| S:123 E:124 ||| -LRB-
BAH ||| S:124 E:127 ||| NNP
) ||| S:127 E:128 ||| -RRB-
.  ||| S:128 E:130 ||| .
From  ||| S:130 E:135 ||| IN
October  ||| S:135 E:143 ||| NNP
2009  ||| S:143 E:148 ||| CD
to  ||| S:148 E:151 ||| TO
August  ||| S:151 E:158 ||| NNP
2013 ||| S:158 E:162 ||| CD
,  ||| S:162 E:164 ||| ,
10  ||| S:164 E:167 ||| CD
193  ||| S:167 E:171 ||| CD
magnetic  ||| S:171 E:180 ||| JJ
resonance  ||| S:180 E:190 ||| NN
angiogram  ||| S:190 E:200 ||| NNS
( ||| S:200 E:201 ||| -LRB-
MRA ||| S:201 E:204 ||| NNP
)  ||| S:204 E:206 ||| -RRB-
and  ||| S:206 E:210 ||| CC
31  ||| S:210 E:213 ||| CD
716  ||| S:213 E:217 ||| CD
magnetic  ||| S:217 E:226 ||| JJ
resonance  ||| S:226 E:236 ||| NN
imaging  ||| S:236 E:244 ||| NN
( ||| S:244 E:245 ||| -LRB-
MRI ||| S:245 E:248 ||| NNP
)  ||| S:248 E:250 ||| -RRB-
consecutive  ||| S:250 E:262 ||| JJ
cases  ||| S:262 E:268 ||| NNS
were  ||| S:268 E:273 ||| VBD
retrospectively  ||| S:273 E:289 ||| JJ
retrieved  ||| S:289 E:299 ||| NN
from  ||| S:299 E:304 ||| IN
our  ||| S:304 E:308 ||| PRP$
institutional  ||| S:308 E:322 ||| JJ
Picture  ||| S:322 E:330 ||| NNP
Archiving  ||| S:330 E:340 ||| NNP
and  ||| S:340 E:344 ||| CC
Communication  ||| S:344 E:358 ||| NNP
System  ||| S:358 E:365 ||| NNP
( ||| S:365 E:366 ||| -LRB-
PACS ||| S:366 E:370 ||| NNP
)  ||| S:370 E:372 ||| -RRB-
database ||| S:372 E:380 ||| NN
.  ||| S:380 E:382 ||| .
BAH  ||| S:382 E:386 ||| NNP
was  ||| S:386 E:390 ||| VBD
defined  ||| S:390 E:398 ||| VBN
as  ||| S:398 E:401 ||| IN
a  ||| S:401 E:403 ||| DT
continuous  ||| S:403 E:414 ||| JJ
diameter  ||| S:414 E:423 ||| JJ
reduction  ||| S:423 E:433 ||| NN
all  ||| S:433 E:437 ||| RB
over  ||| S:437 E:442 ||| IN
artery  ||| S:442 E:449 ||| NN
and  ||| S:449 E:453 ||| CC
a  ||| S:453 E:455 ||| DT
basilar  ||| S:455 E:463 ||| JJ
artery  ||| S:463 E:470 ||| NN
diameter  ||| S:470 E:479 ||| VBD
â‰¤  ||| S:479 E:481 ||| CD
2  ||| S:481 E:483 ||| CD
mm ||| S:483 E:485 ||| NNS
.  ||| S:485 E:487 ||| .
The  ||| S:487 E:491 ||| DT
same  ||| S:491 E:496 ||| JJ
cut-off  ||| S:496 E:504 ||| JJ
value  ||| S:504 E:510 ||| NN
was  ||| S:510 E:514 ||| VBD
applied  ||| S:514 E:522 ||| VBN
for  ||| S:522 E:526 ||| IN
vertebral  ||| S:526 E:536 ||| JJ
artery  ||| S:536 E:543 ||| NN
hypoplasia  ||| S:543 E:554 ||| NNS
( ||| S:554 E:555 ||| -LRB-
VAH ||| S:555 E:558 ||| NNP
) ||| S:558 E:559 ||| -RRB-
.  ||| S:559 E:561 ||| .
We  ||| S:561 E:564 ||| PRP
measured  ||| S:564 E:573 ||| VBD
the  ||| S:573 E:577 ||| DT
diameters  ||| S:577 E:587 ||| NN
of  ||| S:587 E:590 ||| IN
basilar  ||| S:590 E:598 ||| NN
and  ||| S:598 E:602 ||| CC
vertebral  ||| S:602 E:612 ||| JJ
arteries  ||| S:612 E:621 ||| NNS
with  ||| S:621 E:626 ||| IN
PACS  ||| S:626 E:631 ||| NNS
in  ||| S:631 E:634 ||| IN
all  ||| S:634 E:638 ||| DT
patients  ||| S:638 E:647 ||| NNS
according  ||| S:647 E:657 ||| VBG
to  ||| S:657 E:660 ||| TO
source  ||| S:660 E:667 ||| NN
imaging  ||| S:667 E:675 ||| NN
and  ||| S:675 E:679 ||| CC
IMP  ||| S:679 E:683 ||| NNP
construction  ||| S:683 E:696 ||| NN
of  ||| S:696 E:699 ||| IN
MRA ||| S:699 E:702 ||| NNP
.  ||| S:702 E:704 ||| .
The  ||| S:704 E:708 ||| DT
carotid  ||| S:708 E:716 ||| FW
arterial  ||| S:716 E:725 ||| FW
computed  ||| S:725 E:734 ||| FW
tomography  ||| S:734 E:745 ||| FW
angiogram  ||| S:745 E:755 ||| FW
( ||| S:755 E:756 ||| -LRB-
CTA ||| S:756 E:759 ||| NNP
)  ||| S:759 E:761 ||| -RRB-
profiles  ||| S:761 E:770 ||| NNS
were  ||| S:770 E:775 ||| VBD
reviewed  ||| S:775 E:784 ||| VBN
in  ||| S:784 E:787 ||| IN
50  ||| S:787 E:790 ||| CD
patients ||| S:790 E:798 ||| NNS
.  ||| S:798 E:800 ||| .
The  ||| S:800 E:804 ||| DT
fetal-type  ||| S:804 E:815 ||| JJ
posterior  ||| S:815 E:825 ||| JJ
circle  ||| S:825 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
Willis  ||| S:835 E:842 ||| NNP
( ||| S:842 E:843 ||| -LRB-
FTP ||| S:843 E:846 ||| NNP
)  ||| S:846 E:848 ||| -RRB-
was  ||| S:848 E:852 ||| VBD
assessed ||| S:852 E:860 ||| VBN
.  ||| S:860 E:862 ||| .
The  ||| S:862 E:866 ||| DT
diagnosis  ||| S:866 E:876 ||| NN
of  ||| S:876 E:879 ||| IN
acute  ||| S:879 E:885 ||| JJ
cerebral  ||| S:885 E:894 ||| JJ
infarction  ||| S:894 E:905 ||| NN
was  ||| S:905 E:909 ||| VBD
based  ||| S:909 E:915 ||| VBN
on  ||| S:915 E:918 ||| IN
clinical  ||| S:918 E:927 ||| JJ
symptoms ||| S:927 E:935 ||| NNS
,  ||| S:935 E:937 ||| ,
signs  ||| S:937 E:943 ||| NNS
and  ||| S:943 E:947 ||| CC
a  ||| S:947 E:949 ||| DT
high  ||| S:949 E:954 ||| JJ
signal  ||| S:954 E:961 ||| NN
on  ||| S:961 E:964 ||| IN
diffusion-weighted  ||| S:964 E:983 ||| JJ
imaging  ||| S:983 E:991 ||| NN
( ||| S:991 E:992 ||| -LRB-
DWI ||| S:992 E:995 ||| NNP
) ||| S:995 E:996 ||| -RRB-
.  ||| S:996 E:998 ||| .
Acute  ||| S:998 E:1004 ||| JJ
cerebral  ||| S:1004 E:1013 ||| JJ
infarction  ||| S:1013 E:1024 ||| NN
was  ||| S:1024 E:1028 ||| VBD
divided  ||| S:1028 E:1036 ||| VBN
into  ||| S:1036 E:1041 ||| IN
anterior  ||| S:1041 E:1050 ||| JJ
circulation  ||| S:1050 E:1062 ||| NN
stroke  ||| S:1062 E:1069 ||| NN
( ||| S:1069 E:1070 ||| -LRB-
ACS ||| S:1070 E:1073 ||| NNP
)  ||| S:1073 E:1075 ||| -RRB-
and  ||| S:1075 E:1079 ||| CC
posterior  ||| S:1079 E:1089 ||| JJ
circulation  ||| S:1089 E:1101 ||| NN
stroke  ||| S:1101 E:1108 ||| NN
( ||| S:1108 E:1109 ||| -LRB-
PCS ||| S:1109 E:1112 ||| NNP
) ||| S:1112 E:1113 ||| -RRB-
.  ||| S:1113 E:1115 ||| .
A  ||| S:1115 E:1117 ||| DT
total  ||| S:1117 E:1123 ||| NN
of  ||| S:1123 E:1126 ||| IN
210  ||| S:1126 E:1130 ||| CD
BAH  ||| S:1130 E:1134 ||| NNP
were  ||| S:1134 E:1139 ||| VBD
identified  ||| S:1139 E:1150 ||| VBN
among  ||| S:1150 E:1156 ||| IN
10  ||| S:1156 E:1159 ||| CD
193  ||| S:1159 E:1163 ||| CD
consecutive  ||| S:1163 E:1175 ||| JJ
patients ||| S:1175 E:1183 ||| NNS
.  ||| S:1183 E:1185 ||| .
BAH  ||| S:1185 E:1189 ||| NNP
was  ||| S:1189 E:1193 ||| VBD
more  ||| S:1193 E:1198 ||| RBR
common  ||| S:1198 E:1205 ||| JJ
in  ||| S:1205 E:1208 ||| IN
females  ||| S:1208 E:1216 ||| NNS
( ||| S:1216 E:1217 ||| -LRB-
56.7 ||| S:1217 E:1221 ||| NNP
% ||| S:1221 E:1222 ||| NN
)  ||| S:1222 E:1224 ||| -RRB-
than  ||| S:1224 E:1229 ||| IN
males  ||| S:1229 E:1235 ||| NNS
( ||| S:1235 E:1236 ||| -LRB-
43.3 ||| S:1236 E:1240 ||| CD
% ||| S:1240 E:1241 ||| NN
)  ||| S:1241 E:1243 ||| -RRB-
in  ||| S:1243 E:1246 ||| IN
the  ||| S:1246 E:1250 ||| DT
patient  ||| S:1250 E:1258 ||| JJ
group ||| S:1258 E:1263 ||| NN
.  ||| S:1263 E:1265 ||| .
They  ||| S:1265 E:1270 ||| PRP
had  ||| S:1270 E:1274 ||| VBD
a  ||| S:1274 E:1276 ||| DT
fetal-type  ||| S:1276 E:1287 ||| JJ
of  ||| S:1287 E:1290 ||| IN
posterior  ||| S:1290 E:1300 ||| JJ
cerebral  ||| S:1300 E:1309 ||| JJ
artery  ||| S:1309 E:1316 ||| NN
( ||| S:1316 E:1317 ||| -LRB-
FTP ||| S:1317 E:1320 ||| NNP
)  ||| S:1320 E:1322 ||| -RRB-
( ||| S:1322 E:1323 ||| -LRB-
175  ||| S:1323 E:1327 ||| CD
bilateral  ||| S:1327 E:1337 ||| NNS
( ||| S:1337 E:1338 ||| -LRB-
83.3 ||| S:1338 E:1342 ||| CD
% ||| S:1342 E:1343 ||| NN
) ||| S:1343 E:1344 ||| -RRB-
,  ||| S:1344 E:1346 ||| ,
35  ||| S:1346 E:1349 ||| CD
unilateral  ||| S:1349 E:1360 ||| NNS
( ||| S:1360 E:1361 ||| -LRB-
16.7 ||| S:1361 E:1365 ||| CD
% ||| S:1365 E:1366 ||| NN
) ||| S:1366 E:1367 ||| -RRB-
) ||| S:1367 E:1368 ||| -RRB-
.  ||| S:1368 E:1370 ||| .
99.5 ||| S:1370 E:1374 ||| CD
%  ||| S:1374 E:1376 ||| NN
patients  ||| S:1376 E:1385 ||| NNS
had  ||| S:1385 E:1389 ||| VBD
V4  ||| S:1389 E:1392 ||| NNP
VAH  ||| S:1392 E:1396 ||| NNP
and  ||| S:1396 E:1400 ||| CC
56.0 ||| S:1400 E:1404 ||| CD
%  ||| S:1404 E:1406 ||| NN
( ||| S:1406 E:1407 ||| -LRB-
28 ||| S:1407 E:1409 ||| CD
/ ||| S:1409 E:1410 ||| CD
50 ||| S:1410 E:1412 ||| CD
)  ||| S:1412 E:1414 ||| -RRB-
V1-V3  ||| S:1414 E:1420 ||| NNP
VAH ||| S:1420 E:1423 ||| NNP
.  ||| S:1423 E:1425 ||| .
Among  ||| S:1425 E:1431 ||| IN
210  ||| S:1431 E:1435 ||| CD
BAH ||| S:1435 E:1438 ||| NNP
,  ||| S:1438 E:1440 ||| ,
there  ||| S:1440 E:1446 ||| EX
are  ||| S:1446 E:1450 ||| VBP
74  ||| S:1450 E:1453 ||| CD
patients  ||| S:1453 E:1462 ||| NNS
( ||| S:1462 E:1463 ||| -LRB-
mean  ||| S:1463 E:1468 ||| JJ
age  ||| S:1468 E:1472 ||| NN
64  ||| S:1472 E:1475 ||| CD
years ||| S:1475 E:1480 ||| NNS
,  ||| S:1480 E:1482 ||| ,
average  ||| S:1482 E:1490 ||| JJ
25-91  ||| S:1490 E:1496 ||| CD
years ||| S:1496 E:1501 ||| NNS
,  ||| S:1501 E:1503 ||| ,
44  ||| S:1503 E:1506 ||| CD
males ||| S:1506 E:1511 ||| NNS
)  ||| S:1511 E:1513 ||| -RRB-
with  ||| S:1513 E:1518 ||| IN
a  ||| S:1518 E:1520 ||| DT
diagnosis  ||| S:1520 E:1530 ||| NN
of  ||| S:1530 E:1533 ||| IN
acute  ||| S:1533 E:1539 ||| FW
cerebral  ||| S:1539 E:1548 ||| FW
infarction  ||| S:1548 E:1559 ||| FW
( ||| S:1559 E:1560 ||| -LRB-
ACI ||| S:1560 E:1563 ||| NNP
) ||| S:1563 E:1564 ||| -RRB-
.  ||| S:1564 E:1566 ||| .
The  ||| S:1566 E:1570 ||| DT
males  ||| S:1570 E:1576 ||| NNS
were  ||| S:1576 E:1581 ||| VBD
predominant  ||| S:1581 E:1593 ||| VBN
in  ||| S:1593 E:1596 ||| IN
ACI  ||| S:1596 E:1600 ||| NNP
( ||| S:1600 E:1601 ||| -LRB-
59.5 ||| S:1601 E:1605 ||| CD
%  ||| S:1605 E:1607 ||| NN
in  ||| S:1607 E:1610 ||| IN
males  ||| S:1610 E:1616 ||| NNS
vs  ||| S:1616 E:1619 ||| VBD
40.5 ||| S:1619 E:1623 ||| CD
%  ||| S:1623 E:1625 ||| NN
in  ||| S:1625 E:1628 ||| IN
females ||| S:1628 E:1635 ||| NNS
,  ||| S:1635 E:1637 ||| ,
P  ||| S:1637 E:1639 ||| NN
=  ||| S:1639 E:1641 ||| SYM
0.021 ||| S:1641 E:1646 ||| CD
) ||| S:1646 E:1647 ||| -RRB-
.  ||| S:1647 E:1649 ||| .
The  ||| S:1649 E:1653 ||| DT
frequency  ||| S:1653 E:1663 ||| NN
of  ||| S:1663 E:1666 ||| IN
BAH  ||| S:1666 E:1670 ||| NNP
was  ||| S:1670 E:1674 ||| VBD
detected  ||| S:1674 E:1683 ||| VBN
in  ||| S:1683 E:1686 ||| IN
74  ||| S:1686 E:1689 ||| CD
( ||| S:1689 E:1690 ||| -LRB-
2.2 ||| S:1690 E:1693 ||| CD
% ||| S:1693 E:1694 ||| NN
)  ||| S:1694 E:1696 ||| -RRB-
among  ||| S:1696 E:1702 ||| IN
3  ||| S:1702 E:1704 ||| CD
294  ||| S:1704 E:1708 ||| CD
ACI  ||| S:1708 E:1712 ||| NN
patients ||| S:1712 E:1720 ||| NNS
.  ||| S:1720 E:1722 ||| .
As  ||| S:1722 E:1725 ||| IN
a  ||| S:1725 E:1727 ||| DT
relatively  ||| S:1727 E:1738 ||| RB
rare  ||| S:1738 E:1743 ||| JJ
vascular  ||| S:1743 E:1752 ||| JJ
abnormality ||| S:1752 E:1763 ||| NN
,  ||| S:1763 E:1765 ||| ,
BAH  ||| S:1765 E:1769 ||| NNP
has  ||| S:1769 E:1773 ||| VBZ
always  ||| S:1773 E:1780 ||| RB
unilateral  ||| S:1780 E:1791 ||| JJ
or  ||| S:1791 E:1794 ||| CC
bilateral  ||| S:1794 E:1804 ||| JJ
FTP  ||| S:1804 E:1808 ||| NNP
and  ||| S:1808 E:1812 ||| CC
V4  ||| S:1812 E:1815 ||| NNP
VAH ||| S:1815 E:1818 ||| NNP
.  ||| S:1818 E:1820 ||| .
